Richard J Gralla


Ontology type: schema:Person     


Person Info

NAME

Richard J

SURNAME

Gralla

Publications in SciGraph latest 50 shown

  • 2018-09-26 Pulmonary Toxicities of Anticancer Treatment in THE MASCC TEXTBOOK OF CANCER SUPPORTIVE CARE AND SURVIVORSHIP
  • 2018-07 Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT) in SUPPORTIVE CARE IN CANCER
  • 2018-07 Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients in SUPPORTIVE CARE IN CANCER
  • 2017-05 Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists in SUPPORTIVE CARE IN CANCER
  • 2017-01 Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2017-01 MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update in SUPPORTIVE CARE IN CANCER
  • 2017-01 2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents in SUPPORTIVE CARE IN CANCER
  • 2017-01 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2016-11 Efficacy benefit of an NK1 receptor antagonist (NK1RA) in patients receiving carboplatin: supportive evidence with NEPA (a fixed combination of the NK1 RA, netupitant, and palonosetron) and aprepitant regimens in SUPPORTIVE CARE IN CANCER
  • 2016-06 Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials) in CURRENT ONCOLOGY REPORTS
  • 2015-06 Determining issues of importance for the evaluation of quality of life and patient-reported outcomes in breast cancer: results of a survey of 1072 patients in BREAST CANCER RESEARCH AND TREATMENT
  • 2015-03 Comparison of an extended-release formulation of granisetron (APF530) versus palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately or highly emetogenic chemotherapy: results of a prospective, randomized, double-blind, noninferiority phase 3 trial in SUPPORTIVE CARE IN CANCER
  • 2013-03 A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer in SUPPORTIVE CARE IN CANCER
  • 2013-01 Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL) in SUPPORTIVE CARE IN CANCER
  • 2012-11 Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial in SUPPORTIVE CARE IN CANCER
  • 2011-03 Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: Guideline update and results of the Perugia consensus conference in SUPPORTIVE CARE IN CANCER
  • 2011-03 Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only) in SUPPORTIVE CARE IN CANCER
  • 2011-03 Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—state of the art in SUPPORTIVE CARE IN CANCER
  • 2010-09-03 Quality-of-Life Assessment: The Challenge of Incorporating Quality-of-Life and Patient-Reported Outcomes into Investigative Trials and Clinical Practice in THE MASCC TEXTBOOK OF CANCER SUPPORTIVE CARE AND SURVIVORSHIP
  • 2009-06 Evolving lipid-based delivery systems in the management of neoplastic disease in ONCOLOGY REVIEWS
  • 2009-03 Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS) in SUPPORTIVE CARE IN CANCER
  • 2007-07 Oral Vinorelbine in the Treatment of Non-Small Cell Lung Cancer in DRUGS
  • 2006-04 Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response in SUPPORTIVE CARE IN CANCER
  • 2006-01 Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso in SUPPORTIVE CARE IN CANCER
  • 2005-04 A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): Does format affect patient ratings of symptoms and quality of life? in QUALITY OF LIFE RESEARCH
  • 2005-02 The 2004 Perugia Antiemetic Consensus Guideline process: methods, procedures, and participants in SUPPORTIVE CARE IN CANCER
  • 2005-02 Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update in SUPPORTIVE CARE IN CANCER
  • 2005-02 Delayed emesis: moderately emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 2004-11 Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer in SUPPORTIVE CARE IN CANCER
  • 2002-10 Antiemetic guidelines: creating a more practical treatment approach in SUPPORTIVE CARE IN CANCER
  • 1999-04 Normative data and trends in quality of life from the Lung Cancer Symptom Scale (LCSS) in SUPPORTIVE CARE IN CANCER
  • 1998-04 Methodology of antiemetic trials: response assessment, evaluation of new agents and definition of chemotherapy emetogenicity in SUPPORTIVE CARE IN CANCER
  • 1998-04 Consensus proposal for 5HT3 antagonists in the prevention of acute emesis related to highly emetogenic chemotherapy in SUPPORTIVE CARE IN CANCER
  • 1998 Consensus Proposal for 5-HT3 Antagonists in the Prevention of Acute Emesis Related to Highly Emetogenic Chemotherapy in PERUGIA CONSENSUS CONFERENCE ON ANTIEMETIC THERAPY
  • 1998 Methodology of Antiemetic Trials: Response Assessment, Evaluation of New Agents, and Definition of Chemotherapy Emetogenicity in PERUGIA CONSENSUS CONFERENCE ON ANTIEMETIC THERAPY
  • 1997-07 Clinical and methodological issues in antiemetic therapy: a worldwide survey of experts' opinions in SUPPORTIVE CARE IN CANCER
  • 1997-01 Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis in SUPPORTIVE CARE IN CANCER
  • 1996 Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis in SUPPORTIVE CARE IN CANCER
  • 1994-09 Antiemetic treatment for cancer chemotherapy: problems and progress in SUPPORTIVE CARE IN CANCER
  • 1994-07 Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS) in SUPPORTIVE CARE IN CANCER
  • 1993-11 Dose-ranging evaluation of the substituted benzamide dazopride when used as an antiemetic in patients receiving anticancer chemotherapy in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1993-07 Progress in controlling emesis with cancer chemotherapy in SUPPORTIVE CARE IN CANCER
  • 1993-07 Delayed emesis: a dilemma in antiemetic control in SUPPORTIVE CARE IN CANCER
  • 1991-10 Controlling cancer chemotherapy-induced emesis in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
  • 1991-05 Phase II trial of esorubicin (4′deoxydoxorubicin, DxDx) in patients with small cell lung cancer in INVESTIGATIONAL NEW DRUGS
  • 1991 Controlling Emesis in Patients Receiving Cancer Chemotherapy in SUPPORTIVE CARE IN CANCER PATIENTS II
  • 1988 Controlling Emesis in Patients Receiving Cancer Chemotherapy in SUPPORTIVE CARE IN CANCER PATIENTS
  • 1984-02 Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1983-05 Antiemetics: A Round Table Discussion in DRUGS
  • 1983-05 Metoclopramide in DRUGS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.251993.5", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.239585.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1013.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411900.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416477.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.449071.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.427738.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240416.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416735.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21729.3f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.257060.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418624.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240845.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.59062.38", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415224.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.32224.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417993.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414636.2", 
            "type": "Organization"
          }
        ], 
        "familyName": "Gralla", 
        "givenName": "Richard J", 
        "id": "sg:person.01001652730.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001652730.28"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:14", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_911.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01001652730.28'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01001652730.28'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01001652730.28'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01001652730.28'


     

    This table displays all metadata directly associated to this object as RDF triples.

    56 TRIPLES      10 PREDICATES      31 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01001652730.28 schema:affiliation N944fcf5d82824877aaf1907b325766e1
    2 https://www.grid.ac/institutes/grid.1013.3
    3 https://www.grid.ac/institutes/grid.21729.3f
    4 https://www.grid.ac/institutes/grid.239585.0
    5 https://www.grid.ac/institutes/grid.240145.6
    6 https://www.grid.ac/institutes/grid.240416.5
    7 https://www.grid.ac/institutes/grid.240845.f
    8 https://www.grid.ac/institutes/grid.257060.6
    9 https://www.grid.ac/institutes/grid.32224.35
    10 https://www.grid.ac/institutes/grid.411900.d
    11 https://www.grid.ac/institutes/grid.414636.2
    12 https://www.grid.ac/institutes/grid.415224.4
    13 https://www.grid.ac/institutes/grid.416477.7
    14 https://www.grid.ac/institutes/grid.416735.2
    15 https://www.grid.ac/institutes/grid.417993.1
    16 https://www.grid.ac/institutes/grid.418624.d
    17 https://www.grid.ac/institutes/grid.427738.d
    18 https://www.grid.ac/institutes/grid.449071.f
    19 https://www.grid.ac/institutes/grid.51462.34
    20 https://www.grid.ac/institutes/grid.5386.8
    21 https://www.grid.ac/institutes/grid.59062.38
    22 schema:familyName Gralla
    23 schema:givenName Richard J
    24 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001652730.28
    25 schema:sdDatePublished 2019-03-07T15:14
    26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    27 schema:sdPublisher Ne66fd7304b714599821577a49525d81b
    28 sgo:license sg:explorer/license/
    29 sgo:sdDataset persons
    30 rdf:type schema:Person
    31 N944fcf5d82824877aaf1907b325766e1 schema:affiliation https://www.grid.ac/institutes/grid.251993.5
    32 sgo:isCurrent true
    33 rdf:type schema:OrganizationRole
    34 Ne66fd7304b714599821577a49525d81b schema:name Springer Nature - SN SciGraph project
    35 rdf:type schema:Organization
    36 https://www.grid.ac/institutes/grid.1013.3 schema:Organization
    37 https://www.grid.ac/institutes/grid.21729.3f schema:Organization
    38 https://www.grid.ac/institutes/grid.239585.0 schema:Organization
    39 https://www.grid.ac/institutes/grid.240145.6 schema:Organization
    40 https://www.grid.ac/institutes/grid.240416.5 schema:Organization
    41 https://www.grid.ac/institutes/grid.240845.f schema:Organization
    42 https://www.grid.ac/institutes/grid.251993.5 schema:Organization
    43 https://www.grid.ac/institutes/grid.257060.6 schema:Organization
    44 https://www.grid.ac/institutes/grid.32224.35 schema:Organization
    45 https://www.grid.ac/institutes/grid.411900.d schema:Organization
    46 https://www.grid.ac/institutes/grid.414636.2 schema:Organization
    47 https://www.grid.ac/institutes/grid.415224.4 schema:Organization
    48 https://www.grid.ac/institutes/grid.416477.7 schema:Organization
    49 https://www.grid.ac/institutes/grid.416735.2 schema:Organization
    50 https://www.grid.ac/institutes/grid.417993.1 schema:Organization
    51 https://www.grid.ac/institutes/grid.418624.d schema:Organization
    52 https://www.grid.ac/institutes/grid.427738.d schema:Organization
    53 https://www.grid.ac/institutes/grid.449071.f schema:Organization
    54 https://www.grid.ac/institutes/grid.51462.34 schema:Organization
    55 https://www.grid.ac/institutes/grid.5386.8 schema:Organization
    56 https://www.grid.ac/institutes/grid.59062.38 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...